//www.igerbera.com en-us Mon, 23 Jan 2023 00:00:00 GMT Mon, 23 Jan 2023 11:45:27 GMT Silverchair jamams@jamanetwork.org support@www.igerbera.com //www.igerbera.com/journals/jamainternalmedicine/fullarticle/2800830 Mon, 23 Jan 2023 00:00:00 GMT In this issue of JAMA Internal Medicine, Forbes et al reported a randomized clinical trial, the Infection Control in ERCP using a Duodenoscope with a Disposable Cap (ICECAP) trial, which examines the effects on persistent microbial contamination of duodenoscopes with disposable elevator caps as compared with duodenoscopes with standard designs in patients undergoing endoscopic retrograde cholangiopancreatography (ERCP). The trial found that the disposable elevator cap duodenoscopes had reduced rates of bacterial contamination as compared with duodenoscopes with standard designs, without affecting the technical quality and safety of ERCP. The study addresses the continuing public health concern about the transmission of bacteria to patients by contaminated duodenoscopes. 10.1001/jamainternmed.2022.6393 2800830 //www.igerbera.com/journals/jamainternalmedicine/fullarticle/2800828 Mon, 23 Jan 2023 00:00:00 GMT 这个随机临床试验确定contamination rates after high-level disinfection and technical performance of duodenoscopes with disposable elevator caps compared with those with standard designs. 10.1001/jamainternmed.2022.6394 2800828 //www.igerbera.com/journals/jamainternalmedicine/fullarticle/2800827 Mon, 23 Jan 2023 00:00:00 GMT This essay describes the author’s experience with a socially isolated patient who declined cancer treatment because he had no one to help him after transarterial radioembolization therapy. 10.1001/jamainternmed.2022.6304 2800827 //www.igerbera.com/journals/jamanetworkopen/fullarticle/2800704 Mon, 23 Jan 2023 00:00:00 GMT This comparative effectiveness research study compares outcomes of first-line therapy with immune checkpoint inhibitors vs chemotherapy among patients who have metastatic colorectal cancer with high microsatellite instability, mismatch repair deficiency, and/or high tumor mutational burden. 6 1 e2252244 10.1001/jamanetworkopen.2022.52244 2800704 //www.igerbera.com/journals/jamanetworkopen/fullarticle/2800686 Fri, 20 Jan 2023 00:00:00 GMT This case series examines transcriptomic factors associated with outcomes in patients with rectal cancer who received neoadjuvant chemoradiotherapy. 6 1 e2252140 10.1001/jamanetworkopen.2022.52140 2800686

map